The relationship between insulin resistance and plasminogen activator inhibitor type-1 in hypertensive patients
Pi-Neng LU,Cheng-Bin XU,Hai-Cheng ZHANG,Hong HAN
DOI: https://doi.org/10.3321/j.issn:1671-167X.1999.03.026
1999-01-01
Abstract:Objective: To investigate the relationship between insulin resistance (ISR) and plasminogen activator inhibitor type 1(PAI 1) in essential hypertensive patients( EH). Methods:59 EH patients, and 46 controls were investigated. Body mass index(BMI),waist/hip ratio(WHR), plasma PAI 1 antigen,tissue type plasminogen activator(tPA), triglyceride( TG) , high density lipoprotein cholesterol( HDL C), low density lipoprotein cholesterol(LDL C), uric acid(UA), fasting glucose(GLU) and insulin(INS) levels were measured, and insulin sensitivity determined by insulin sensitive index(ISI), namely 1/(GLU×INS). Results: Compared with controls, in EH group, ISI was lower (-5.4±0.5 vs -3.9±0.8, P 0.01), and plasma PAI 1 antigen was higher [(29±8) vs (24±5) mg·L -1 , P 0.05].PAI 1 correlated significantly with insulin resistance,represented by ISI( r =-0.301, P 0.05). PAI 1 also correlated significantly with WHR( r =0.369, P 0.01),GLU( r =0.563, P 0.001),HDL C( r =-0.417, P 0.01), and tPA( r = -0.499 , P 0.001). Multiple regression analysis including indices of BMI,WHR,ISI,HDL C,LDL C, TG, UA,tPA,PAI 1, and INS disclosed ISI to account for 8.0% of variance of PAI 1antigen( P = 0.024 ). Conclusion:ISR and higher PAI 1 level were seen in EH patients. PAI 1 higher correlated with ISI, tPA, WHR, HDL C PAI 1 independently correlated with ISR.